Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ara Metjian

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Peyvandi F, Cataland S, Scully M, Coppo P, Knoebl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Minkue Mi Edou J, De Winter H, Callewaert F. Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood Adv. 2021 Apr 27; 5(8):2137-2141. PMID: 33881463.
      View in: PubMed
    2. Yuan X, Yu J, Gerber G, Chaturvedi S, Cole M, Chen H, Metjian A, Sperati CJ, Braunstein EM, Brodsky RA. Ex vivo assays to detect complement activation in complementopathies. Clin Immunol. 2020 12; 221:108616. PMID: 33148511.
      View in: PubMed
    3. Hanlon A, Metjian A. Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura. Ther Adv Hematol. 2020; 11:2040620720902904. PMID: 32095224.
      View in: PubMed
    4. Knoebl P, Cataland S, Peyvandi F, Coppo P, Scully M, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Minkue Mi Edou J, De Winter H, Callewaert F. Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. J Thromb Haemost. 2020 02; 18(2):479-484. PMID: 31691462.
      View in: PubMed
    5. Zwicker JI, Muia J, Dolatshahi L, Westfield LA, Nieters P, Rodrigues A, Hamdan A, Antun AG, Metjian A, Sadler JE. Adjuvant low-dose rituximab and plasma exchange for acquired TTP. Blood. 2019 09 26; 134(13):1106-1109. PMID: 31331919.
      View in: PubMed
    6. Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 01 24; 380(4):335-346. PMID: 30625070.
      View in: PubMed
    7. Diep R, Metjian A. A rare CALR variant mutation and a review of CALR in essential thrombocythemia. J Thromb Thrombolysis. 2018 Apr; 45(3):457-462. PMID: 29411299.
      View in: PubMed
    8. Onwuemene OA, Grambow SC, Patel CB, Mentz RJ, Milano CA, Rogers JG, Metjian AD, Arepally GM, Ortel TL. Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study. J Clin Apher. 2018 Aug; 33(4):469-479. PMID: 29524240.
      View in: PubMed
    9. Tanhehco YC, Arepally G, Metjian A. Novel therapeutic approaches for thrombotic thrombocytopenic purpura. Curr Opin Hematol. 2017 Nov; 24(6):521-528. PMID: 28759473.
      View in: PubMed
    10. Abbes S, Metjian A, Gray A, Martinu T, Snyder L, Chen DF, Ellis M, Arepally GM, Onwuemene O. Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. Ther Apher Dial. 2017 Oct; 21(5):441-450. PMID: 28880430.
      View in: PubMed
    11. Metjian A, Tanhehco YC, Aqui N, Bhoj VG, Jamensky L, Marques MB, Onwuemene O, Pham HP, Arepally GM. The thrombotic microangiopathy Registry of North America: A United States multi-institutional TMA network. J Clin Apher. 2016 Oct; 31(5):448-53. PMID: 26575088.
      View in: PubMed
    12. Metjian AD. rVWF: treatment finally reaches the modern age. Blood. 2015 Oct 22; 126(17):1975-6. PMID: 26494919.
      View in: PubMed
    13. Nipp R, Mitchell A, Pishko A, Metjian A. Waldenström macroglobulinemia in hepatitis C: case report and review of the current literature. Case Rep Oncol Med. 2014; 2014:165670. PMID: 25247100.
      View in: PubMed
    14. Patil AS, Dotters-Katz SK, Metjian AD, James AH, Swamy GK. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy. Obstet Gynecol. 2013 Aug; 122(2 Pt 2):483-485. PMID: 23884268.
      View in: PubMed
    15. Sood SL, Cuker A, Wang C, Metjian AD, Chiang EY, Soucie JM, Konkle BA. Similarity in joint function limitation in Type 3 von Willebrand's disease and moderate haemophilia A. Haemophilia. 2013 Jul; 19(4):595-601. PMID: 23534856.
      View in: PubMed
    16. Lee G, Duan-Porter W, Metjian AD. Acquired, non-amyloid related factor X deficiency: review of the literature. Haemophilia. 2012 Sep; 18(5):655-63. PMID: 23437437.
      View in: PubMed
    17. Whitlatch NL, Kong DF, Metjian AD, Arepally GM, Ortel TL. Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia. Blood. 2010 Sep 09; 116(10):1761-6. PMID: 20508160.
      View in: PubMed
    18. Metjian A, Abrams CS. New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. Biologics. 2009; 3:499-513. PMID: 20054440.
      View in: PubMed
    19. Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA. Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia. 2009 Jul; 15(4):918-25. PMID: 19473418.
      View in: PubMed
    20. Metjian A, Lim W. ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Hematology Am Soc Hematol Educ Program. 2009; 247-9. PMID: 20008205.
      View in: PubMed
    21. Metjian A, Abrams CS. New insights and therapeutics for immune-mediated thrombocytopenia. Expert Rev Cardiovasc Ther. 2008 Jan; 6(1):71-84. PMID: 18095908.
      View in: PubMed
    22. Metjian A, Roll RL, Ma AD, Abrams CS. Agonists cause nuclear translocation of phosphatidylinositol 3-kinase gamma. A Gbetagamma-dependent pathway that requires the p110gamma amino terminus. J Biol Chem. 1999 Sep 24; 274(39):27943-7. PMID: 10488142.
      View in: PubMed
    23. Ma AD, Metjian A, Bagrodia S, Taylor S, Abrams CS. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase gamma, a Rac guanosine exchange factor, and Rac. Mol Cell Biol. 1998 Aug; 18(8):4744-51. PMID: 9671484.
      View in: PubMed
    Metjian's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)